Reuters
reuters.com
did:plc:jbvnehrrdqoulco4rf5gxg5r
Novo Nordisk's next-gen obesity drug outperforms Wegovy in late-stage diabetes trial reut.rs/49T35w6 https://reut.rs/49T35w6
2026-02-02T21:10:19.156Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.